Amylyx Pharmaceuticals Inc (AMLX)
Stock-Based Compensation
$8.32M
Quarterly · Period ending: · USD
AMLX Stock-Based Compensation
Latest reported$8.32Mperiod ending
Latest reported$8.32Mperiod ending
AMLX Quarterly Stock-Based Comp ($0.00 → $8.32M)
Quarterly stock-based compensation
High-resolution chart · PNG
AMLX stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 8,318,000 | |
| 6,120,000 | |
| 6,386,000 | |
| 7,076,000 | |
| 7,350,000 | |
| 6,833,000 | |
| 6,741,000 | |
| 6,803,000 | |
| 9,570,000 | |
| 9,924,000 | |
| 9,534,000 | |
| 10,176,000 | |
| 9,950,000 | |
| 7,501,000 | |
| 6,091,000 | |
| 5,524,000 | |
| 5,707,000 | |
| 4,392,000 | |
| 1,091,000 | |
| 0 | |
| 657,000 | |
| 586,000 | |
| 0 |